Benefit, rather than safety, of cilostazol for long-term mortality in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized trials

被引：12
作者：
Takagi, Hisato [1 ]
Umemoto, Takuya [1 ]
机构：
[1] Shizuoka Med Ctr, Dept Cardiovasc Surg, Shimizu, Shizuoka 4118611, Japan
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2011年 / 153卷 / 01期
关键词：
Cilostazol; Meta-analysis; Mortality; Percutaneous coronary intervention; Randomized controlled trial; TRIPLE ANTIPLATELET THERAPY; ELUTING STENT IMPLANTATION; LATE LUMEN LOSS; LATE RESTENOSIS; TICLOPIDINE; CLOPIDOGREL; DISEASE; ASPIRIN; PREVENTION; OUTCOMES;
D O I：
10.1016/j.ijcard.2011.07.072
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：74 / 76
页数：3
相关论文
共 29 条
[1]  
AHN CM, 2010, HEART VESSELS 1209
[2]   Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients - Clilostazol for Diabetic Patients in Drug-Eluting Stent (CIDES) trial [J].
Ahn, Youngkeun ;
Jeong, Myung Ho ;
Jeong, Jong Weon ;
Kim, Kye Hun ;
Ahn, Tae Hoon ;
Kang, Woong Chul ;
Park, Chang-Gyu ;
Kim, Jong Hyun ;
Chae, In-Ho ;
Nam, Chang Wook ;
Hur, Seung-Ho ;
Bae, Jang-Ho ;
Kim, Ki Young ;
Oh, Seok Kyu .
CIRCULATION JOURNAL, 2008, 72 (01) :35-39
[3]   Cilostazol: A review of its use in intermittent claudication [J].
Therese M. Chapman ;
Karen L. Goa .
American Journal of Cardiovascular Drugs, 2003, 3 (2) :117-138
[4]   A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent [J].
Chen, YD ;
Lu, YL ;
Jin, ZN ;
Yuan, F ;
Lü, SZ .
CHINESE MEDICAL JOURNAL, 2006, 119 (05) :360-366
[5]   Coronary stent restenosis in patients treated with cilostazol [J].
Douglas, JS ;
Holmes, DR ;
Kereiakes, DJ ;
Grines, CL ;
Block, E ;
Ghazzal, ZMB ;
Morris, DC ;
Liberman, H ;
Parker, K ;
Jurkovitz, C ;
Murrah, N ;
Foster, J ;
Hyde, P ;
Mancini, GBJ ;
Weintraub, WS .
CIRCULATION, 2005, 112 (18) :2826-2832
[6]   RACTS: A prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting long-term clinical and angiographic outcome - Long-term clinical and angiographic outcome [J].
Ge, JB ;
Han, YL ;
Jiang, H ;
Sun, BG ;
Chen, JY ;
Zhang, SY ;
Du, ZM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (02) :162-166
[7]   Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study [J].
Han, Yaling ;
Li, Yi ;
Wang, Shouli ;
Jing, Quanmin ;
Wang, Zhulu ;
Wang, Dongmei ;
Shu, Qingfen ;
Tang, Xiuying .
AMERICAN HEART JOURNAL, 2009, 157 (04) :733-739
[8]   Cilostazol improves long-term outcomes after coronary stent implantation [J].
Han, YL ;
Wang, SL ;
Li, Y ;
Jing, QM ;
Ma, YY ;
Deng, J ;
Yang, GT ;
Yu, HB ;
Ge, JB .
AMERICAN HEART JOURNAL, 2005, 150 (03) :568.e1-568.e5
[9]   Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) [J].
Hiatt, William R. ;
Money, Samuel R. ;
Brass, Eric P. .
JOURNAL OF VASCULAR SURGERY, 2008, 47 (02) :330-336
[10]   Addition of Cilostazol to Aspirin and a Thienopyridine for Prevention of Restenosis After Coronary Artery Stenting: A Meta-Analysis [J].
Jennings, Douglas L. ;
Kalus, James S. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (04) :415-421
123